Retreatment with bevacizumab in patients with recurrent ovarian cancer does not increase morbidity and has a favorable disease response
Year: 2012
Type: article
Source: Gynecologic Oncology
Institution: Magee-Womens Hospital
Language: English
Subfield: Reproductive Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2316860375
